A prospective study comparing the pharmacokinetics, efficacy, and side effects of sunitinib in patients with advanced renal cell carcinoma
Latest Information Update: 08 Aug 2018
At a glance
- Drugs Sunitinib (Primary)
- Indications Renal cell carcinoma
- Focus Adverse reactions; Pharmacokinetics
Most Recent Events
- 03 Aug 2018 Status changed from recruiting to completed.
- 05 Aug 2014 New trial record